Certified by Founder
Lodge
Cytospire Therapeutics Ltd
start up
- 07/05/2026
- Series A
- $82,984,705
Cytospire Therapeutics is developing a portfolio of next generation immune cell engagers
- Industry Biotechnology Research
- Website https://www.cytospire.com/
- LinkedIn https://www.linkedin.com/company/cytospire-therapeutics-ltd/
Related People
Natalie MountFounder
United Kingdom -
London, England
Immuno-Oncology
Cell and Gene Therapy
Biotech leadership
Preclinical Development
Translational Medicine
Clinical Development
Iceotope | $26,000,000 | (May 15, 2026)
Harken Sweets | Undisclosed Amount | (May 15, 2026)
Graphon AI | $8,300,000 | (May 15, 2026)
Ranger AI | $8,400,000 | (May 15, 2026)
Wirestock | $23,000,000 | (May 15, 2026)
GridCARE | $64,000,000 | (May 15, 2026)
Chromie Health | $2,000,000 | (May 15, 2026)
Novella | $21,000,000 | (May 15, 2026)
Flick | $6,000,000 | (May 15, 2026)
Synthetic | $10,000,000 | (May 14, 2026)
SwishX | $2,200,000 | (May 14, 2026)
Urologic Health | $11,000,000 | (May 14, 2026)